Chrome Extension
WeChat Mini Program
Use on ChatGLM

AZD7442 (tixagevimab/cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019

CLINICAL INFECTIOUS DISEASES(2023)

Cited 10|Views18
Key words
COVID-19,AZD7442,monoclonal antibodies,post-exposure prophylaxis,SARS-CoV-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined